Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Robert Fico wins Slovakia election with anti-Ukraine stance
    • Republican hardliner moves to oust Kevin McCarthy over deal to avert shutdown
    • Germans shrug off economic gloom at booming Oktoberfest
    • US lawmakers pass short-term deal to avoid government shutdown
    • Biden seeks to reassure Ukraine as war aid becomes US political battleground
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Octopus Energy: the UK start-up outgrowing its roots
      • UBS settles with Mozambique in Credit Suisse ‘tuna bond’ case
      • Revolut attracts UK watchdog scrutiny over red-flag accounts
      • US hedge fund provides record loan for environmental lawsuits
      • Looney accused of promoting BP women with whom he had undisclosed relationships
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • VCs tell start-ups to delay IPO plans after Arm and Instacart underwhelm
      • Revolut attracts UK watchdog scrutiny over red-flag accounts
      • ‘Talk to everyone you can’: Plaid’s Zach Perret on navigating a failed sale and Covid upheaval
      • The debt-fuelled bet on US Treasuries that’s scaring regulators
      • Afghan currency posts world-beating rally in third quarter
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Germany must invest to neutralise the far-right threat
      • Russia and North Korea are baring their teeth
      • Global lessons from inflation’s rise above the UK target
      • Hit the snooze button: it’s good for you
      • Inheritance tax debates overlook the psychology of the thing
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • The ghastly modern office needs a reboot
      • ‘Talk to everyone you can’: Plaid’s Zach Perret on navigating a failed sale and Covid upheaval
      • Why personal conduct is a growing risk for business
      • Labour conference will be so full of execs it will look like Davos, only in Liverpool
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Japan’s toddler superstar: the baby bringing hope to a ghost village
      • Four unmissable meals – with hotels attached
      • Bismarck, Truss and why timing is everything in politics
      • Return of the Caesars: the making of emperors and dictators
      • My dad, the demigod
    • HTSI
    1. Companies
    2. Health
    • Healthcare
    • Pharmaceuticals
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Health

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Monday, 2 October, 2023
      Special ReportFT Health Centre
      FT Health: Future of Antibiotics

      The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

      3 hours ago
      Pharmacy cashier Silvia Carballo wearing a face mask and gloves counts bills at ‘Farmacia de la Estrella’ on April 08, 2020 in Buenos Aires
    • Monday, 2 October, 2023
      Anna Berkeley
      Ask a Stylist: what’s a smart-casual look for walking the dog?

      As the weather changes, choose practical footwear — and there’s no need to put a muzzle on the choice of accessories

      3 hours ago
      Jennifer Lawrence in a dog-walking outfit in New York
    • Monday, 2 October, 2023
      Special ReportFT Health: Future of Antibiotics
      Ukraine infections show rising threat from antibiotic resistance

      Economic and political fallout from war distracts governments from health threats

      3 hours ago
      A paramedic measures the blood pressure of a wounded soldier at a mobile clinic
    • Sunday, 1 October, 2023
      The Big Read
      Artificial sweeteners: the health controversy that will not go away

      Recent warnings are the latest in a series of scares, but the industry says sugar substitutes remain a vital weapon against obesity and diabetes

      Image shows Prof Dana Small, some brain dissections, saccharin tablets, and a diagram of E951 (aspartame) taken from the European Food Safety Authority site
    • Saturday, 30 September, 2023
      Isabel Berwick
      Hit the snooze button: it’s good for you

      Getting up to exercise at 4am like a CEO isn’t all it’s cracked up to be — the real health benefits are for later risers

      A cat wakes up Audrey Hepburn in the 1961 film ‘Breakfast at Tiffany’s’
    • Friday, 29 September, 2023
      The best books of the week
      The infected blood scandal — and how it was allowed to happen

      Victims still await compensation from a case of shocking government indifference, professional malpractice and commercial greed

      A demonstrator wearing a black T-shirt emblazoned with the words ‘contaminated blood scandal’ — plus ‘They called us cheaper than chimps, thick, useful material, the great unwashed and virgin haemophiliacs’
    • Friday, 29 September, 2023
      Demographics and population
      Why are white Britons dying at higher rates than other ethnic groups?

      New mortality data could help create targeted policy to reduce the UK’s large and growing disease burden

      A doctor with a stethoscope round his neck talking to a patient
    • Wednesday, 27 September, 2023
      National Health Service
      Rising attrition rate for NHS workers shown in study

      Many doctors, nurses and other staff who enter professional training never join full-time workforce, Nuffield Trust finds

      Nurses on ward
    • Wednesday, 27 September, 2023
      Novo Nordisk AS
      Prescriptions surge for Novo Nordisk’s Ozempic and similar drugs

      Report shows 300% increase in demand for GLP-1 weight loss and diabetes drugs

      A scientist uses a culture flask and pipette in the cell therapy labs at the Novo Nordiskv research facilities in Malov, Denmark
    • Tuesday, 26 September, 2023
      Anjana Ahuja
      ‘Inverse vaccines’ could turn autoimmune treatment upside down

      The latest findings build on experiments from over a century ago

      Ann Kiernan illustration of a woman getting ready to inject herself with a vaccine
    • Tuesday, 26 September, 2023
      Covid-19 vaccines
      EU in talks with Moderna over new vaccine supply deal

      Brussels launches talks for mRNA jabs to augment existing contract with BioNTech/Pfizer

      A pharmacist administers a Covid jab made by Moderna
    • Monday, 25 September, 2023
      Coronavirus treatment
      Covid antiviral drug linked to ‘transmissible’ mutations, research finds

      Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient

      An experimental COVID-19 treatment pill, called molnupiravir
    • Saturday, 23 September, 2023
      Camilla Cavendish
      Britain should lead in life sciences but NHS inertia is holding it back

      Biobank deadlock is a symptom of the UK’s ailing innovation sector

      Illustration of a person merging with a data chip with lots of red crosses and padlocks in the background
    • Friday, 22 September, 2023
      UK politics
      Sunak considers move to ban smoking for next generation

      Prime minister’s latest effort to tackle falling ratings could trigger party backlash

      Cigarette in ashtray
    • Thursday, 21 September, 2023
      National Health Service
      Number of UK nursing students plummets despite NHS shortages

      Low wages and student debt worries are believed to have undermined applications, putting workforce plan in doubt

      A nurse walks through an NHS hospital ward
    • Wednesday, 20 September, 2023
      Mental health
      Suppressing negative thoughts good for mental health, researchers find

      Cambridge university study contradicts common belief in psychology that it is better to talk about distressing ideas and memories

      An elderly woman dozes in the garden
    • Wednesday, 20 September, 2023
      FT Globetrotter
      Running in Milan: five great routes

      From beloved landmarks to showstopping starchitecture via lush green spaces and a main waterway, these runs reveal everything that gives the city its grande brio

      Joggers running alongside Milan’s Grand Canal
    • Tuesday, 19 September, 2023
      Artificial intelligence
      DeepMind uses AI to predict harmful genetic mutations in humans

      First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants

      An artist’s illustration of how artificial intelligence can predict patterns in biology
    • Monday, 18 September, 2023
      OutlookPatti Waldmeir
      Tactics are shifting in the war on drugs

      Experimentation continues on measures to tackle addiction and fatal overdoses

      A box containing naloxone overdose emergency kits outside a store at Canal Park in Pennsylvania
    • Monday, 18 September, 2023
      The Big Read
      The Biden administration takes on the US drugs industry

      New rules are designed to make medicines cheaper for American seniors. But companies warn innovation will suffer

    • Sunday, 17 September, 2023
      National Health Service
      NHS braced for unprecedented strikes as doctors in England walk out

      Four days of industrial action includes co-ordinated walkout by consultants and junior medics

      Medical consultant members of the British Medical Association (BMA) on the picket line outside University College London hospital
    • Sunday, 17 September, 2023
      Coronavirus
      WHO chief pushes China for ‘full access’ to solve Covid’s origins

      Tedros Adhanom Ghebreyesus says health body is ready to send second mission as Omicron variants drive rise in cases

      Tedros Adhanom Ghebreyesus
    • Friday, 15 September, 2023
      House & Home
      The secret history of the teenager’s bedroom

      Parents have always fretted about what goes on behind closed doors — but societal shifts and tech dominance mean concerns are now more fraught

    • Friday, 15 September, 2023
      Travel
      Bed and breakfast with the Buddha

      South Korea’s ‘templestay’ programme offers accommodation — and a taste of inner peace — at monasteries across the country

      A traditionally decorated Buddhist temple with an ornate mokoshi roof carvings and a golden Buddha statue
    • Friday, 15 September, 2023
      FT MagazineTim Harford
      The art of making good mistakes

      Neither organisations nor people can learn from their errors if they deny mistakes ever happened

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Health Technology Summit
    Powering innovation across health systems
    Thursday, 30 NovemberDigital Conference
    FT Live
    US Pharma and Biotech Summit
    Exploring trends and innovations in life sciences across the United States
    Tuesday, 14 May 2024New York, NY, USA
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In